Biotech

All Articles

Novo inks $600M NanoVation package to research genetic drugs ex-liver

.Novo Nordisk is continuing its push right into genetic medicines, accepting pay NanoVation Therapie...

Innovent web links cytokine to intestines cancer feedbacks

.Innovent Biologics has created the instance that its own gate inhibitor-cytokine fusion protein has...

Merck, Daiichi ADC attacks target in stage 3 lung cancer cells research study

.A period 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate ...

Rakovina deepens artificial intelligence concentrate along with collab to choose cancer cells intendeds

.5 months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has act...

Ascendis' dwarfism drug favorites in phase 3, threatens BioMarin

.Ascendis Pharma has actually become a prospective risk to BioMarin's Voxzogo, stating phase 3 growt...

Despite ph. 3 skip, Alkeus views pathway in advance for eye condition resource

.Though Alkeus Pharmaceuticals' oral eye condition possession neglected to dramatically lower geogra...

Kairos goes social with $6M IPO to cash tests of cancer medicine

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was actually simple to miss out on...

Vaccine as well as Keytruda combination reliable in squamous tissue carcinoma

.Immune checkpoint inhibitors are the superheroes of cancer treatment. Medications like Bristol Myer...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of significant management hirings, shootings and...

Regeneron's Opdualag opponent shows 57% response rate

.Regeneron is back with long-term follow-up for its own LAG-3 inhibitor and PD-1 prevention combinat...